Applications of inorganic nanoparticles for biotechnology

Frontiers of Nanoscience

Volumn 4, Issue 1, 2012, Pages 159-180

  Berry, Catherine C ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NANOPARTICLES;

INORGANIC NANOPARTICLE;

BIOTECHNOLOGY;

EID: 84872763028     PISSN: 18762778     EISSN: 1876276X     Source Type: Book Series    
DOI: 10.1016/B978-0-12-415769-9.00006-6     Document Type: Chapter

References (132)

1. Bhupender S, Sekhon S, Seema R, Kamboj R. Inorganic nanomedicine-part 1. Nanomed Nanotechnol Biol Med 2010;6:516-22.
2. Berry CC. Progress in functionalization of magnetic nanoparticles for applications in biomedicine. J Phys D Appl Phys 2009;42:224003.
3. Koo H, Huh MS, Sun IC, Yuk SH, Choi K, Kim K, et al. In vivo targeted delivery of nanoparticles for theranosis. Acc Chem Res 2011;44:1018-28.
4. Bae KH, Chung HJ, Park TG. Nanomaterials for cancer therapy and imaging. Mol Cells 2011;31:295-302.
5. Huang HC, Barua S, Sharma G, Dey SK, Rege K. Inorganic nanoparticles for cancer imaging and therapy. J Control Release 2011;155:344-57.
6. Connolly J, St. Pierre TG, Rutnakornpituk M, Riffle JS. Cobalt nanoparticles formed in polysiloxane copolymer micelles: effect of production methods on magnetic properties. J Phys D Appl Phys 2004;37:2475.
7. Xu C, Sun S. Superparamagnetic nanoparticles as targeted probes for diagnostic and therapeutic applications. Dalton Trans 2009;29:5583-91.
8. Brigger I, Dubernet C, Couvreue P. Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev 2002;13:631-51.
9. Dobson J. Nanoscale biogenic iron oxides and neurodegenerative disease. FEBS Lett 2001;496:1-5.
10. Bulte JW, Douglas T, Witwer B. Magnetodendrimers allow endosomal magnetic labelling and in vivo tracking of stem cells. Nat Biotechnol 2001;19:1141-7.
11. Berry CC, Wells S, Charles S, Curtis ASG. Dextran and albumin derivatised nanoparticles: influence on fibroblasts in vitro. Biomaterials 2003;24:4551-7.
12. Berry CC, Wells S, Charles S, Atchinson G, Curtis ASG. Biomaterials 2004;25:5405-541.
13. Soenan SJH, Vercauteren D, Braeckmans K, Noppe W, de Smelt S, de Cuyper M. Stable long-term intracellular labelling with fluorescently tagged cationic magnetic liposomes. Chembiochem 2009;10:257-67.
14. Enochs WS, Harsh F, Hochberg F, Weissledher R. Improved delineation of human brain tumors on MR images using a long-circulating, superparamagnetic iron oxide agent. J Magn Reson Imaging 1999;9:228-32.
15. Varallyay P, Nesbit G, Muldoon LL, Nixon RR, Delashaw JI, Cohen JI, et al. Comparison of two superparamagnetic viral-sized iron oxide particles ferumoxides and ferumoxtran-10 with a gadolinium chelate in imaging intracranial tumors. AJNR Am J Neuroradiol 2002;23:510-9.
16. Varallyay P, Nesbit G, Muldoon LL, Nixon RR, Delashaw J, Cohen JI. Comparison of two superparamagnetic viral-sized nanoparticles ferumoxides and ferumoxtran-10 with a gadolinium chelate in imaging intracranial tumors. Am J Neuroradiol 2002;23:510-9.
17. Babincova M, Altanerova V, Altaner C, Cicmanex P, Babinec P. In vivo heating of magnetic nanoparticles in an alternating magnetic field. Med Phys 2004;31:2219-21.
18. Barry SE. Challenges in the development of magnetic particles for therapeutic applications. Int J Hyperthermia 2008;24:451-566.
19. Cerdan S, Lotscher HR, Kunnecke B, Seeling J. Monoclonal antibody-coated magnetite particles as contrast agents in magnetic resonance imaging of tumors. Magn Reson Med 1989;12:151-63.
20. Bulte JW, Hoekstra Y, Kamman RL, Magin RL, Webb AG, Briggs RW, et al. Specific MR imaging of human lymphocytes by monoclonal antibody-guided dextran-magnetite particles. Magn Reson Med 1992;25:148-57.
21. Suzuki M, Honda H, Kobayashi T, Wakabayashi T, Yoshida J, Takahashi M. Development of a target directed magnetic resonance contrast agent using monoclonal antibodyconjugated magnetic nanoparticles. Brain Tumor Pathol 1996;13:127-32.
22. Huh YM. In vivo magnetic resonance detection of cancer by using multifunctional magnetic nanocrystals. J Am Chem Soc 2006;127:12387-91.
23. Arternov D, Mori N, Okollie B, Bhujwalla AM. MR imaging of the HER-2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles. Magn Reson Med 2003;49:403-8.
24. Toma A, Otsuji E, Kuriu Y, Okamoto K, Ichikawa D, Hagiwara A, et al. Monoclonal antibody A7-superparamagnetic iron oxide as contrast agent of MR imaging of rectal carcinoma. Br J Cancer 2005;93:131-6.
25. Funovics MA, Kapeller B, Hoeller C, Su HS, Kunstfield R, Puig S, et al. MR imaging of the her2/neu and 9.2.27 tumor antigens using immunospecific contrast agents. Magn Reson Imaging 2004;22:843-50.
26. Zhou Y, Drummond DC, Zou H, Hayes ME, Adams GP, Kirpotin DB, et al. Impact of single-chain Fv antibody fragment affinity on nanoparticle targeting of epidermal growth factor receptor-expressing tumor cells. J Mol Biol 2007;371:934-47.
27. Yang L, Mao H, Want A, Cao Z, Peng X, Wang X, et al. Single chain epidermal growth factor receptor antibody conjugated nanoparticles for in vivo tumor targeting and imaging. Small 2009;2:235-43.
28. Jun YW, Huh YM, Choi JS, Lee JH, Song HT, Kim S, et al. Nanoscale size effect of magnetic nanocrystals and their utilization for cancer diagnosis via magnetic resonance imaging. J Am Chem Soc 2005;127:5732-3.
29. Lee JH, Huh YM, Jun Y, Seo J, Jang J, Song HT, et al. Artificially engineered magnetic nanoparticles for ultra sensitive molecular imaging. Nat Med 2007;13:95-9.
30. McCarthy JR, Weissleder R. Multifunctional magnetic nanoparticles for targeted imaging and therapy. Adv Drug Deliv Rev 2008;60:1241-51.
31. Masashige S. Functional magnetic particles for medical application. J Biosci Bioeng 2002;94:606-13.
32. Fortin JP, Gaxeau G, Wilhelm C. Intracellular heating of living cells through Neel relaxation of magnetic nanoparticles. Eur Biophys J 2008;37:223-8.
33. Gazeau F, Levy M, Wilhelm C. Optimizing magnetic nanoparticle design for nanothermotherapy. Nanomedicine 2008;3:831-44.
34. Giri J, Ray A, Dasgupta S, Datta D, Bahadur D. Investigation of Tc tuned nanoparticles of magnetic oxides for hyperthermia applications. Biomed Mater Eng 2003;13:387-99.
35. Jordan A, Scholz R, Wust P, Fahling H, Felix R. Magnetic fluid hyperthermia (MFH): cancer treatment with AC magnetic field inducted excitation of biocompatible superparamagnetic nanoparticles. J Magn Magn Mater 1999;201:413-9.
36. Jordan A, Scholz R, Maier-Hauff K, Johannsen M, Wust P, Nadobny J. Presentation of a new magnetic field therapy system for the treatment of human solid tumors with magnetic fluid hyperthermia. J Magn Magn Mater 2001;225:118-26.
37. Ito A, Kuga Y, Honda H, Kikkawa H, Horiuchi A, Watanabe Y, et al. Magnetite nanoparticleloaded anti-HER2 immunoliposomes for combination of antibody therapy with hyperthermia. Cancer Lett 2004;212:167-75.
38. Jin H, Kang KA. Application of novel metal nanoparticles as optical/thermal agents in optical mammography and hyperthermic treatment for breast cancer. Adv Exp Med Biol 2007;599:45-52.
39. Salloum M, Ma RH, Weeks D, Zhu L. Controlling nanoparticle delivery in magnetic nanoparticle hyperthermia for cancer treatment: experimental study in agarose gel. Int J Hyperthermia 2008;24:337-45.
40. Johannsen M, Gneveckow U, Thiesen B, Taymoorian K, Cho CH, Waldofner N. Thermotherapy of prostate cancer using magnetic nanoparticles: feasibility, imaging, and threedimensional temperature distribution. Eur Urol 2007;52:1653-62.
41. Wust P, Gneveckow U, Johannsen M, Bohmer D, Henkel T, Kahmann F. Magnetic nanoparticles for interstitial thermotherapy-feasibility, tolerance and achieved temperatures. Int J Hyperthermia 2006;22:673-85.
42. Van Landeghem FKH, Maier-Hauff K, Jordan A, Hoffmann KT, Gneveckow R, Scholz R, et al. Post-mortem studies in glioblastoma patients treated with thermotherapy using magnetic nanoparticles. Biomaterials 2009;30:52-7.
43. Kim DH, Kim KN, Kim KM, Lee YK. Targeting to carcinoma cells with chitosan and starch coated magnetic nanoparticles for magnetic hyperthermia. J BiomedMater Res 2008;88A:1-11.
44. DeNardo SJ, DeNArdo GL, Miers LA, Natarajan A, Foreman AR, Gruettner C, et al. Development of tumor targeting bioprobes (111In-chimeric L6 monoclonal antibody nanoparticles) for alternating magnetic field cancer therapy. Clin Cancer Res 2005;11:7087-92.
45. Naratajan A, Gruettner R, Ivkov GL, DeNardo G, Mirick A, Yuan A, et al. Nanoferrite particle based radioimmunonanoparticles: binding affinity and in vivo pharmacokinetics. Bioconjug Chem 2008;19:1211-8.
46. Walther W, Stein U, Schlag P. Use of the human MRD1 promotor for heat-inducible expression of therapeutic genes. Int J Cancer 2002;98:291-6.
47. Ito A, Shinkai M, Honda H, Kobayashi T. Heat-inducible TNF-alpha gene therapy combined with hyperthermia using magnetic nanoparticles as a novel tumor-targeted therapy. Cancer Gene Ther 2001;8:649-54.
48. Tang QS, Zhang DS, Cong XM, Wan ML, Jin LQ. Using thermal energy produced by irradiation of Mn-Zn ferrite magnetic nanoparticles (MZF-NPs) for heat-inducible gene expression. Biomaterials 2008;29:2673-9.
49. Dobson J. Magnetic nanoparticles for drug delivery. Drug Dev Res 2006;67:55-60.
50. Dejardin T, de la Fuente J, Pino P, Furlani EP, Mullin M, Smith CA, et al. The influence of both a static magnetic field and penetratin on magnetic nanoparticle delivery into fibroblasts. Nanomedicine 2011;6:1719-31.
51. Smith CA, de la Fuente J, Pelaz B, Furlani EP, Mullin M, Berry CC. The effect of static magnetic fields and tat peptides on cellular and nuclear uptake of magnetic nanoparticles. Biomaterials 2010;15:4392-400.
52. Lubbe AS, Alexiou C, Bergmann C. Clinical applications of magnetic drug targeting. J Surg Res 1999;95:200-6.
53. Lubbe AS, Bergmann C, Brock J, McClure DG. Physiological aspects in magnetic drug targeting. J Magn Magn Mater 2000;194:149-55.
54. Briley-Saebo K, Bjornerud A, Grant D, Ahlstrom H, Berg T, Kindberg GM. Hepatic cellular distribution and degradation of iron oxide nanoparticles following single intravenous injection in rats: implications for magnetic resonance imaging. Cell Tissue Res 2004;316:315-23.
55. Grief AD, Richardson G. Mathematical modelling of magnetically targeted drug delivery. J Magn Magn Mater 2005;293:455-63.
56. Jain TK, Morales MA, Sahoo SK, Leslie-Pelecky DL, Labhasetwar V. Iron oxide nanoparticles for sustained delivery of anticancer agents. Mol Pharm 2005;2:194-205.
57. Kohler N, Sun C, Fichtenholz A, Gunn J, Fang C, Zhang MQ. Methotrexate-immobilised poly(ethylene glycol) magnetic nanoparticles for MR imaging and drug delivery. Small 2006;2:785-92.
58. McBain SC, Yiu HH, Dobson J. Magnetic nanoparticles for gene and drug delivery. Int J Nanomed 2008;3:169-80.
59. Hirao K, Sugita T, Kubo T, Igarashi K, Tanimoto K, Murakami T, et al. Targeted gene delivery to human osteocarcinoma cells with magnetic cationic liposomes under a magnetic field. Int J Oncol 2003;22:1065-71.
60. Haim H, Steiner I, Panet A. Synchronised infection of cell cultures by magnetically controlled virus. J Virol 2005;79:622-5.
61. Furlani EP, Ng KC. Nanoscale magnetic biotransport with application to magnetofection. Phys Rev 2008;77:0619141-8.
62. Dobson J. Gene therapy progress and prospectives: magnetic nanoparticle-based gene delivery. Gene Ther 2006;13:283-7.
63. Mykhaylyk O, Antequera YS, Vlaskou D, Plank C. Generation of magnetic nonviral gene transfer agents and magnetofection in vitro. Nat Protoc 2007;2:2391-411.
64. Fire A, Xu SQ, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998;391:806-11.
65. Gondi CS, Rao JS. Concepts in in vivo siRNA delivery for cancer therapy. J Cell Physiol 2009;220:285-91.
66. Juliano R, Alam MR, Dixit V, Kang H. Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides. Nucleic Acids Res 2008;36:4158-71.
67. Derfus AM, Chen AA, Min DH, Ruoslahti E, Bhatia SN. Targeted quantum dot conjugates for siRNA delivery. Bioconjug Chem 2007;18:1391-6.
68. Soutschek J, Akinc A, Bramlage B, Charisse K, Constien R, Donoghue M. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 2004;432:173-8.
69. Medarova Z, Pham W, Farrar C, Petkova V, Moore A. In vivo imaging of siRNA delivery and silencing in tumors. Nat Med 2007;13:372-7.
70. Lee JH, Lee K, Moon SH, Lee Y, Park TG, Cheon J. All-in-one target-cell-specific magnetic nanoparticles for simultaneous molecular imaging and siRNA delivery. Angew Chem Int Ed 2009;48:4174-9.
71. Arap W, Pasqualini R, Ruoslahti E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 1998;279:377-80.
72. Huang XH, Jain PK, El-Sayed IH, El-Sayed MA. Nanomedicine 2007;2:681-93.
73. Sonnichsen C, Franzl T, Wilk T, von Plessen G, Feldmann J, Wilson O, et al. Drastic reduction of plasmon damping in gold nanorods. Phys Rev Lett 2002;88:077402.
74. Boisselier E, Astruc D. Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. Chem Soc Rev 2009;38:1759-82.
75. Souza GR, Christianson DR, Staquicini FI, Ozawa MG, Snyder EY, Sidman RL, et al. Networks of gold nanoparticles and bacteriophage as biological sensors and cell-targeting agents. Proc Natl Acad Sci USA 2006;103:1215-20.
76. Skala MC, Crow MJ, Wax A, Izatt JA. Photothermal optical coherence tomography of epidermal growth factor receptor in live cells using immunotargeted gold nanospheres. Nano Lett 2008;8:3461-7.
77. Yelin D, Oron D, Thiberge S, Moses E, Silberberg Y. Multiphoton plasmon-resonance microscopy. Opt Express 2003;16:1385-91.
78. Sperling RA, Rivera Gil P, Zhang F, Zanella M, Parak WJ. Biological applications of gold nanoparticles. Chem Soc Rev 2008;37:1896-908.
79. Brendayan M. A review of the potential and versatility of colloidal gold cytochemical labelling for molecular morphology. Biotech Histochem 2000;75:203-42.
80. van del Pol AN. Neuronal imaging with colloidal gold. J Microsc 1980;155:27-59.
81. Yang NS, Burkholder J, MArtinell B, McCabe D. In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment. Proc Natl Acad Sci USA 1990;87:9568-72.
82. Kuriyama S, Mitoro A, Tsujinoue H, Nakatani T, Yoshiji H, Tsujimoto T, et al. Particlemediated gene transfer into murine livers using a newly developed gene gun. Gene Ther 2000;7:1132-6.
83. Yang PH, Sun X, Chiu JF, Sun H, Je QY. Transferring-mediated gold nanoparticle cellular uptake. Bioconjug Chem 2005;16:494-6.
84. Chithrani BD, ChanWC. Elucidating the mechanism of cellular uptake and removal of proteincoated gold nanoparticles of different sizes and shapes. Nano Lett 2007;7:1542-50.
85. Feldherr CM, Lanford RE, Akin D. Signal-mediated nuclear transport in simian virus 40- transformed cells is regulated by large tumor antigen. Proc Natl Acad Sci USA 1992;89: 11002-5.
86. Tkachenko AG, Xie H, Coleman D, Glomm W, Ryan J, Anderson MF, et al. Multifunctional gold nanoparticle-peptide complexes for nuclear targeting. J Am Chem Soc 2003;125:4700-1.
87. Berry CC, de la Fuente J, Mullin M, Wai Ling Chu S, Curtis A. Nuclear localisation of HIV- 1 tat functionalised gold nanoparticles. IEEE TNB 2007;6:262-9.
88. Kumar S, Harrison N, Richards-Kortum R, Sokolov K. Plasmonic nanosensors for imaging intracellular biomarkers in live cells. Nano Lett 2007;7:1338-43.
89. Doering WE, Piotti ME, NAtan MJ, Freeman RG. SERS as a foundation for nanoscale optically detected biological labels. Adv Mater 2007;19:3100-8.
90. Mirkin CA, Letsinger RL, Mucic RC, Storhoff JJ. A DNA-based method for rationally assembling nanoparticles into macroscopic materials. Nature 1996;382:607-9.
91. Man JM, Stoeva SI, Mirkin CA. Bio-bar-code-based DNA detection with PCR-like sensitivity. J Am Chem Soc 2004;126:5932-3.
92. He H, Xie C, Ren J. Nonbleaching fluorescence of gold nanoparticles and its applications in cancer cell imaging. Anal Chem 2008;80:5951-7.
93. Dulkeith E, Morteani AC, Niedereichholz T, Klar TA, Feldmann J, Levi SA, et al. Fluorescence quenching f dye molecules near gold nanoparticles: radiative and nonradiative effects. Phys Rev Lett 2002;89:2003002.
94. Dulkeith R, Ringler M, Klar TA, Feldmann J, Munoz JA, Parak WJ. Gold nanoparticles quench fluorescence by phase induced radiative rate suppression. Nano Lett 2005;5:585-9.
95. Alivisatos AP. Semiconductor clusters, nanocrystals, and quantum dots. Science 1996;271: 933-7.
96. Alivisatos AP, Gu W, Larabell C. Quantum dots as cellular probes. Annu Rev Biomed Eng 2005;7:55-76.
97. Bruchez M, Moronne M, Gin P, Weiss S, Alivisatos AP. Semiconductor nanocrystals as fluorescent biological labels. Science 1988;281:2013-6.
98. Michalet X, Pinaud F, Lacoste TD, Dahan M, Bruchez M. Properties of fluorescent semiconductor nanocrystals and their applications to biological labelling. Single Mol 2001;2:261-76.
99. Rosenthal SJ, Tomlinson I, Adkins EM, Schroeter S, Adams S, Swafford L, et al. Targeting cell surface receptors with ligand-conjugated nanocrystals. J Am Chem Soc 2002;124: 4586-94.
100. Wu X, Liu H, Liu J, Haley KN, Treadway JA, Larson JP, et al. Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots. Nat Biotechnol 2003;21:41-6.
101. Yoo J, Kambara T, Gonda K, Higuchi H. Intracellular imaging of targeted proteins labeled with quantum dots. Exp Cell Res 2008;314:3563-9.
102. Berry CC, Harianawala H, Loebus J, Oreffo ROC, de la Fuente J. Enhancement of human bone marrow cell uptake of quantum dots using tat peptide. Curr Nanosci 2009;5:390-5.
103. Okada CY, Rechsteiner M. Introduction of macromolecules into cultured mammalian cells by osmotic lysis of pinocytic vesicles. Cell 1982;29:33-41.
104. Courty S, Luccardini C, Bellaïche Y, Cappello G, Dahan M. Tracking individual kinesin motors in living cells using single quantum dot imaging. Nano Lett 2006;6:1491-5.
105. Kusumi A, Sako Y, Yamamoto M. Conned lateral diffusion of membrane receptors as studied by single particle tracking (nanovid microscopy). Effects of calcium-induced differentiation in cultured epithelial cells. Biophys J 1993;65:2021-40.
106. Chen H, Titushkin I, Stroscio M, Cho M. Altered membrane dynamics of quantum dotconjugated integrins during osteogenic differentiation of human bone marrow derived progenitor cells. Biophys J 2007;92:1399-408.
107. Dubertret B, Skourides P, Norris DJ, Noireaux V, Brivanlou AH, Libchaber A. In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science 2002; 298:1759-62.
108. Axelrod D. Cell surface contacts illuminated by total internal reflection fluorescence. J Cell Biol 1981;89:141-5.
109. Mkerman MA, Chan WCW, Laakkonen P, Chatia SN, Ruoslahti E. Nanocrystal targeting in vivo. Proc Natl Acad Sci USA 2002;99:12617-21.
110. Gao X, Yang L, Petros JA, Marshall FF, Simons J, Nie S. In vivo molecular and cellular imaging with quantum dots. Curr Opin Biotechnol 2004;16:63-72.
111. Nair A, Shen JH, Thevenot P, Zou L, Cai T, Hu ZB, et al. Enhanced intratumoral uptake of quantum dots concealed within hydrogel nanoparticles. Nanotechnology 2008;19:48.
112. Hu R, Yong KT, Roy I, Ding H, Law WC, Cai HX, et al. Functionalized near-infrared quantum dots for in vitro tumor vasculature imaging. Nanotechnology 2010;21:14.
113. Christian S, Pilch J, Akerman ME, Porkka K, Laakkonen P, Ruoslahti E. Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels. J Cell Biol 2003;163:871-8.
114. Kong J, Soh HT, Cassell AM, Quate CF, Dai H. Synthesis of individual single-walled carbon nanotubes on patterned silicon wafers. Nature 1998;395:878-81.
115. Blanco A, Kostarelos K, Partidos CD, Prato M. Biomedical applications of functionalised carbon nanotubes. Chem Commun 2005;5:571-7.
116. O'Connell MJ, Bachilo SM, Huffman CB, Moore VC, Strano MS, Haroz EH, et al. Band gap fluorescence from individual single walled carbon nanotubes. Science 2002;297:593-6.
117. Fabbro A, Cellot G, Prato M, Ballerini L. Interfacing neurons with carbon nanotubes: (re) engineering neuronal signalling. Prog Brain Res 2011;194:241-52.
118. Jang MJ, Namgung S, Hong S, Nam Y. Directional neurite growth using carbon nanotube patterned substrates as a biomimetic cue. Nanotechnology 2010;21:235102-8.
119. Mattson MP, Haddon RC, Rao AM. Molecular functionalization of carbon nanotubes and use as substrates for neuronal growth. J Mol Neurosci 2000;14:175-82.
120. Ni Y, Hu H, Malarkey EB, Zhao B, Montana V, Haddon RC, et al. Chemically functionalized water soluble single-walled carbon nanotubes modulate neurite outgrowth. J Nanosci Nanotechnol 2005;5:1707-12.
121. Cellot G, Cilia E, Cipollone S, Rancic V, Sucapane A, Giordani S, et al. Carbon nanotubes might improve neuronal performance by favouring electrical shortcuts. Nat Nanotechnol 2009;4:126-33.
122. Keefer EW, Botterman BR, Romero MI, Rossi AF, Gross GW. Carbon nanotube coating improves neuronal recordings. Nat Nanotechnol 2008;3:434-9.
123. Shoval A, Adams C, David-Pur M, Shein M, Hanein Y, Sernagor E. Carbon nanotube electrodes for effective interfacing with retinal tissue. Front Neuroeng 2009;2:1-8.
124. Kotov NA, Winter JO, Clements IP, Jan E, Timko BP, Campidelli S, et al. Nanomaterials for neural interfaces. Adv Mater 2009;21:3970-4004.
125. Moon HK, Lee SH, Choi HC. In vivo near-infrared mediated tumor destruction by photothermal effect of carbon nanotubes. ACS Nano 2009;3:370.7-370.3713.
126. Burke A, Ding X, Singh R, Kraft RA, Levi-Polyachenko N, Rylander MN, et al. Long-term survival following a single treatment of kidney tumors with multiwalled carbon nanotubes and near-infrared radiation. Proc Natl Acad Sci USA 2009;106:12897-902.
127. McDevitt MR, Chattopadhyay D, Kappel BJ, Jaggi JS, Schiffman SR, Antczak C, et al. Tumor targeting with antibody-functionalized, radiolabeled carbon nanotubes. J Nucl Med 2007;48:1180-9.
128. Zhou FF, Xing D, Ou ZM, Wu BY, Resasco DE, Chen WR. Cancer photothermal therapy in the near-infrared region using single walled carbon nanotubes. J Biomed Opt 2009;14:021009.
129. Liu Z, Chen K, Davis C, Sherlock S, Cao QZ, Chen XY, et al. Drug delivery with carbon nanotubes for in vivo cancer treatment. Cancer Res 2008;68:6652-60.
130. Liu Z, Fan AC, Rakhra K, Sherlock S, Goodwin A, Chen XY, et al. Supramolecular stacking of doxorubicin on carbon nanotubes for in vivo cancer therapy. Angew Chem Int Ed 2009;48:7668-72.
131. Xiang LZ, Yuan Y, Xing D, Ou ZM, Yang SH, Zhou FF. Photoacoustic molecular imaging with antibody functionalized single walled carbon nanotubes for early diagnosis of tumor. J Biomed Opt 2009;14:021008.
132. Bhirde AA, Patel V, Gavard J, Zhang GF, Sousa AA, Masedunskas A, et al. Targeted killing of cancer cells in vivo and in vitro with EGF-directed carbon nanotube-based drug delivery. ACS Nano 2009;3:307-16.